Drugs / VCR-HIVDNA006-00-VP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00045838 | Aug 2002 → Apr 2003 | — | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VCR-HIVDNA006-00-VP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00045838 ↗ |
| Modality | Vaccine | “multiclade HIV-1 DNA plasmid vaccine” NCT00045838 ↗ |
| Route | Intramuscular | “All participants will receive three injections in an upper arm muscle-one injection a month for three months-with a needle-less device called a Biojector 2000® (Registered Trademark).” NCT00045838 ↗ |